- Home
- QGEN vs TXRH Comparison
QGEN vs TXRH Comparison
Compare QGEN & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | TXRH |
|---|---|---|
| Founded | 1986 | 1993 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.9B |
| IPO Year | 1998 | 2004 |
Fundamental Metrics
Financial Performance| Metric | QGEN | TXRH |
|---|---|---|
| Price | $39.17 | $194.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 18 |
| Target Price | $45.76 | ★ $193.78 |
| AVG Volume (30 Days) | ★ 2.2M | 1.1M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.17% | 1.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.87 |
| Revenue | N/A | N/A |
| Revenue This Year | $8.18 | $13.46 |
| Revenue Next Year | $5.71 | $9.28 |
| P/E Ratio | ★ $24.01 | $101.76 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.53 | $153.83 |
| 52 Week High | $57.82 | $197.00 |
Technical Indicators
Market Signals| Indicator | QGEN | TXRH |
|---|---|---|
| Relative Strength Index (RSI) | 63.87 | 73.53 |
| Support Level | $38.80 | $165.83 |
| Resistance Level | $49.27 | $197.00 |
| Average True Range (ATR) | 0.80 | 5.73 |
| MACD | 0.26 | 2.65 |
| Stochastic Oscillator | 90.18 | 98.83 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches. Geographically, the majority of the firm's restaurants are in the USA, with a few in foreign countries.